-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Abbott Laboratories, Raises Price Target to $123

Benzinga·10/22/2026 11:20:48
语音播报
Baird analyst David Rescott maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $121 to $123.